CUR has also been shown to (a) decrease the expression of phosphorylated forms of EGFR and ERK1/2; (b) induce apoptosis and cell cycle arrest; and (c) inhibit cell proliferation in the aggressive MDA-MB-231 breast cancer cell line in vitro [33,34]. This evidence concerns the gene EGFR and breast cancer.